3D Printed Oral Stents for Patients With Head and Neck Cancer Receiving Radiation Therapy
Primary Purpose
Malignant Head and Neck Neoplasm
Status
Active
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Questionnaire Administration
Stent Device
Sponsored by
About this trial
This is an interventional device feasibility trial for Malignant Head and Neck Neoplasm
Eligibility Criteria
Inclusion Criteria:
- Patient is dispositioned to receive definitive or adjuvant radiotherapy for treatment of a diagnosed head and neck malignancy.
- Treating radiation oncologist has determined the necessity of an oral stent and a device has been fabricated by dentistry at MD Anderson Cancer Center (MDACC).
- Patient has received pre-treatment imaging which includes the mandibular and maxillary dentition.
- Eastern Cooperative Oncology Group performance status (ECOG PS) 0-2.
- Signed study-specific consent form.
Exclusion Criteria:
- No pre-treatment computed tomography (CT) imaging including the maxilla and mandible is available.
- Prior head and neck radiotherapy.
- Severe trismus with an incisal opening of < 10 mm.
- Inability to comply with the study procedures.
- Patients who have received dental stents fabricated outside of MDACC.
Sites / Locations
- M D Anderson Cancer Center
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
3D printed stent+ MDASI-3D Oral Stents Questionnaire
Arm Description
Patients wear a customized 3D printed oral stent over 5-10 minutes in the supine position at the time of radiation simulation, before starting radiation therapy, and in the 3rd to 5th week of radiation therapy. Patients may also optionally wear the commercially-made stent called TruGuard at these timepoints. Ancillary Studies (MDASI-3D Oral Stents Questionnaire)
Outcomes
Primary Outcome Measures
To evaluate whether a customized 3 dimensional (3D) printed oral stent achieves non-inferior levels of patient reported outcomes as the standard dental-fabricated oral stents at the time prior to starting treatment.
The patient will fill out a questionnaire that measures the form and fit of the 3D printed oral stent at specified time points, and this measurement will be compared with a standard stent. Score ranges(0-10) 0 None at all-10 As bad as you can imagine.
Secondary Outcome Measures
Full Information
NCT ID
NCT05126797
First Posted
September 3, 2021
Last Updated
October 5, 2023
Sponsor
M.D. Anderson Cancer Center
Collaborators
National Cancer Institute (NCI)
1. Study Identification
Unique Protocol Identification Number
NCT05126797
Brief Title
3D Printed Oral Stents for Patients With Head and Neck Cancer Receiving Radiation Therapy
Official Title
3D Printed Oral Stents for Patients Receiving Head and Neck Radiation Therapy
Study Type
Interventional
2. Study Status
Record Verification Date
October 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
October 11, 2017 (Actual)
Primary Completion Date
April 30, 2024 (Anticipated)
Study Completion Date
April 30, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
M.D. Anderson Cancer Center
Collaborators
National Cancer Institute (NCI)
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Data Monitoring Committee
No
5. Study Description
Brief Summary
This trial studies how a customized 3D-printed oral stent compares to a standard stent made by a dentist for use in imaging scans in patients with head and neck cancer receiving radiation therapy. Oral stents are designed to help prevent radiation-related side effects while receiving radiation therapy. Traditional oral stents are created by dentists, require at least 2 separate appointments, and may not be as cost-effective. A customized, 3D-printed oral stent may perform as well as a standard stent made by a dentist and have a significantly shorter turnaround to device delivery.
Detailed Description
PRIMARY OBJECTIVES:
I. To evaluate whether a customized 3 dimensional (3D) printed oral stent achieves non-inferior levels of patient reported outcomes as the standard dental-fabricated oral stents at the time prior to starting treatment.
SECONDARY OBJECTIVES:
I. To evaluate the performance of the 3D stent on imaging parameters (i.e. mandibular and soft tissue displacement) for degree of normal tissue sparing.
II. Evaluate the levels of patient reported outcomes after patients have developed side effects from radiation treatment.
III. To evaluate the commercially available TruGuard oral cavity positioning system.
OUTLINE:
Patients wear a customized 3D printed oral stent over 5-10 minutes in the supine position at the time of radiation simulation, before starting radiation therapy, and in the 3rd to 5th week of radiation therapy. Patients may also optionally wear the commercially-made stent called TruGuard at these timepoints.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Malignant Head and Neck Neoplasm
7. Study Design
Primary Purpose
Device Feasibility
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
57 (Actual)
8. Arms, Groups, and Interventions
Arm Title
3D printed stent+ MDASI-3D Oral Stents Questionnaire
Arm Type
Other
Arm Description
Patients wear a customized 3D printed oral stent over 5-10 minutes in the supine position at the time of radiation simulation, before starting radiation therapy, and in the 3rd to 5th week of radiation therapy. Patients may also optionally wear the commercially-made stent called TruGuard at these timepoints. Ancillary Studies (MDASI-3D Oral Stents Questionnaire)
Intervention Type
Other
Intervention Name(s)
Questionnaire Administration
Intervention Description
Ancillary studies
Intervention Type
Device
Intervention Name(s)
Stent Device
Other Intervention Name(s)
Stent
Intervention Description
Wear customized 3D printed oral stent
Primary Outcome Measure Information:
Title
To evaluate whether a customized 3 dimensional (3D) printed oral stent achieves non-inferior levels of patient reported outcomes as the standard dental-fabricated oral stents at the time prior to starting treatment.
Description
The patient will fill out a questionnaire that measures the form and fit of the 3D printed oral stent at specified time points, and this measurement will be compared with a standard stent. Score ranges(0-10) 0 None at all-10 As bad as you can imagine.
Time Frame
up to 2 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patient is dispositioned to receive definitive or adjuvant radiotherapy for treatment of a diagnosed head and neck malignancy.
Treating radiation oncologist has determined the necessity of an oral stent and a device has been fabricated by dentistry at MD Anderson Cancer Center (MDACC).
Patient has received pre-treatment imaging which includes the mandibular and maxillary dentition.
Eastern Cooperative Oncology Group performance status (ECOG PS) 0-2.
Signed study-specific consent form.
Exclusion Criteria:
No pre-treatment computed tomography (CT) imaging including the maxilla and mandible is available.
Prior head and neck radiotherapy.
Severe trismus with an incisal opening of < 10 mm.
Inability to comply with the study procedures.
Patients who have received dental stents fabricated outside of MDACC.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Eugene J Koay
Organizational Affiliation
M.D. Anderson Cancer Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
M D Anderson Cancer Center
City
Houston
State/Province
Texas
ZIP/Postal Code
77030
Country
United States
12. IPD Sharing Statement
Links:
URL
http://www.mdanderson.org
Description
M.D. Anderson Cancer Center
Learn more about this trial
3D Printed Oral Stents for Patients With Head and Neck Cancer Receiving Radiation Therapy
We'll reach out to this number within 24 hrs